Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Aequus BioPharma

- PMLiVE

NICE relents and gives Pixuvri limited backing

Recommends Cell Therapeutics drug for an aggressive form of cancer

- PMLiVE

NICE unmoved by Pixuvri access scheme

England’s HTA body once again denies Cell Therapeutics' blood cancer treatment

National Institute for Health and Care Excellence NICE logo

Cell Therapeutics fails to gain NICE backing for blood cancer drug

Watchdog says not enough evidence to show Pixuvri is more effective than current treatments

- PMLiVE

IQWiG rejects Cell Therapeutics’ Pixuvri

Rules non-Hodgkin lymphoma drug provides 'no additional benefit'

Ronald Berenson to lead Aequus BioPharma

Joins the Cell Therapeutics subsidiary as president and CEO

Cell Therapeutics launches lymphoma drug Pixuvri in Europe

Will initially be available in Sweden, Denmark and Finland

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links